This study examined how pharmaceuticals behave in Swedish wastewater treatment plants (WWTPs) — how much of what we consume ends up in sewage, and how well different treatment designs remove them. It combined 8 years (2001–2009) of nationwide sampling data from research institutes, municipalities, and councils.
Sweden’s WWTPs mainly use biological treatment systems:
Regulations:
Total: ~470 WWTPs (>2,000 pe) treating 1.3×10⁹ m³/year ≈ 90% of urban wastewater.
Pharmaceuticals can:
💡 Key factor: Solid Retention Time (SRT)
🧮 Only <20% of sold drugs reached WWTPs as dissolved parent compounds for most substances. ➡️ Suggests metabolism, degradation, or sorption before arrival.
Pharmaceutical residues are persistent micropollutants. While Sweden’s biological WWTPs remove many effectively, some — particularly β-blockers and diuretics — persist and may impact aquatic ecosystems.
This research is part of MistraPharma, a Swedish strategic project on pharmaceuticals and the environment, funded by Mistra – The Foundation for Strategic Environmental Research.